Statement Article from  Health Canada

Archived - Statement from the Minister of Health on labelling changes for certain homeopathic products

Archived Content

Information identified as archived is provided for reference, research or recordkeeping purposes. It is not subject to the Government of Canada Web Standards and has not been altered or updated since it was archived. Please contact us to request a format other than those available.

July 31, 2015 - Ottawa, ON - Health Canada

OTTAWA - Today, I am taking additional steps to protect and ensure the safety of Canadian children, by introducing changes for certain homeopathic products that fall under the Natural Health Product Regulations (NHPR). Many Canadians choose to purchase natural health products, including homeopathic products, to maintain and improve their health. The Government of Canada is committed to ensuring that they continue to have access to a wide variety of these products, however, current package labelling for some homeopathic products may not be adequate for Canadians to make informed choices. The changes apply to the labelling of some homeopathic products, specifically nosode products as well as homeopathic cough, cold and flu products for children 12 and under.

I am introducing these changes to ensure that Canadian parents who choose to use homeopathic products have the information they need to make informed health choices for themselves and their children.

Today, all nosode product license holders are being made aware of this change. They are requested to include a new statement on nosode labels: “This product is neither a vaccine nor an alternative to vaccination. This product has not been proven to prevent infection. Health Canada does not recommend its use in children and advises that your child receive all routine vaccinations.” Nosode licence holders have been asked to comply with the new labelling changes by January 2016.

Furthermore, Health Canada will no longer approve specific health claims on homeopathic products for cough, cold, and flu for children 12 and under, unless those claims are supported by scientific evidence.

Companies have been asked to comply with this new labelling change by July 2016.

To date, the Department has authorised the sale of 121 nosode products and 139 homeopathic products for cough, cold and flu for children under 12. All those products are included in the scope of the labelling changes as described in the updated monographs, which are available online. The Department has also added information on its website about nosodes and other homeopathic products and how they are regulated.

Following the implementation dates for the new labelling changes, Health Canada Officials will verify that products on the market include the labelling changes and steps will be taken should they not.

As I have mentioned many times before, I continue to encourage vaccination, as it is safe and provides important benefits for our children's health throughout their lives.

Associated Links

Homeopathy Monograph

Nosodes Monograph

Consumer Education – Information on the labelling of homeopathic products

Information Update – Labelling changes to nosodes and children’s cough cold and flu homeopathic products

Contacts

Michael Bolkenius
Office of the Honourable Rona Ambrose
Federal Minister of Health
(613) 957-0200

Health Canada
Media Relations
(613) 957-2983

Public Inquiries:
(613) 957-2991
1-866 225-0709


Search for related information by keyword

Hon. Rona Ambrose Health Canada Health and Safety

Date modified: